Abstract
This article reports on a symposium sponsored by the American Society for Pharmacology and Experimental Therapeutics and held at the April 2001 Experimental Biology meeting. Current developments in molecular-based studies into the structure and function of cholinesterases, carboxylesterases, and paraoxonases are described. This article covers mechanisms of regulation of gene expression of the various esterases by developmental factors and xenobiotics, as well as the interplay between physiological and chemical regulation of enzyme activity.
Footnotes
- Abbreviations used are::
- CES
- carboxylesterase
- kb
- kilobase
- CPT-11
- irinotecan
- SN-38
- 7-ethyl-10-hydroxycamptothecin
- ACE
- angiotensin-converting enzyme
- PON
- paraoxonase
- HDL
- high-density lipoprotein
- Received November 28, 2001.
- Accepted January 22, 2002.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.